Cerebral plasticity: Windows of opportunity in the develo** brain

FY Ismail, A Fatemi, MV Johnston - European journal of paediatric …, 2017 - Elsevier
Background Neuroplasticity refers to the inherently dynamic biological capacity of the central
nervous system (CNS) to undergo maturation, change structurally and functionally in …

Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus

RJ Burman, RE Rosch, JM Wilmshurst, A Sen… - Nature Reviews …, 2022 - nature.com
Status epilepticus is a life-threatening neurological emergency that affects both adults and
children. Approximately 36% of episodes of status epilepticus do not respond to the current …

Chloride transporters controlling neuronal excitability

JC Pressey, M de Saint-Rome… - Physiological …, 2023 - journals.physiology.org
Synaptic inhibition plays a crucial role in regulating neuronal excitability, which is the
foundation of nervous system function. This inhibition is largely mediated by the …

[HTML][HTML] The postnatal GABA shift: a developmental perspective

C Peerboom, CJ Wierenga - Neuroscience & Biobehavioral Reviews, 2021 - Elsevier
GABA is the major inhibitory neurotransmitter that counterbalances excitation in the mature
brain. The inhibitory action of GABA relies on the inflow of chloride ions (Cl−), which …

Noninvasive targeted transcranial neuromodulation via focused ultrasound gated drug release from nanoemulsions

RD Airan, RA Meyer, NPK Ellens, KR Rhodes… - Nano …, 2017 - ACS Publications
Targeted, noninvasive neuromodulation of the brain of an otherwise awake subject could
revolutionize both basic and clinical neuroscience. Toward this goal, we have developed …

[HTML][HTML] CNS pharmacology of NKCC1 inhibitors

W Löscher, K Kaila - Neuropharmacology, 2022 - Elsevier
Abstract The Na–K–2Cl cotransporter NKCC1 and the neuron-specific K–Cl cotransporter
KCC2 are considered attractive CNS drug targets because altered neuronal chloride …

A pilot randomized, controlled, double‐blind trial of bumetanide to treat neonatal seizures

JS Soul, AM Bergin, C Stopp, B Hayes… - Annals of …, 2021 - Wiley Online Library
Objective In the absence of controlled trials, treatment of neonatal seizures has changed
minimally despite poor drug efficacy. We tested bumetanide added to phenobarbital to treat …

Sex differences in the epilepsies and associated comorbidities: implications for use and development of pharmacotherapies

CA Christian, DS Reddy, J Maguire… - Pharmacological Reviews, 2020 - Elsevier
The epilepsies are common neurologic disorders characterized by spontaneous recurrent
seizures. Boys, girls, men, and women of all ages are affected by epilepsy and, in many …

Off-label use of bumetanide for brain disorders: an overview

SC Kharod, SK Kang, SD Kadam - Frontiers in neuroscience, 2019 - frontiersin.org
Bumetanide (BTN or BUM) is a FDA-approved potent loop diuretic (LD) that acts by
antagonizing sodium-potassium-chloride (Na-K-Cl) cotransporters, NKCC1 (SLc12a2) and …

KCC2, epileptiform synchronization, and epileptic disorders

G Di Cristo, PN Awad, S Hamidi, M Avoli - Progress in Neurobiology, 2018 - Elsevier
Abstract The K+-Cl− co-transporter KCC2 is a neuron-specific, Cl− extruder that uses K+
gradient for maintaining low intracellular [Cl−]. It is indeed well established that sustaining …